Influence of the sFlt-1/PlGF ratio on clinical decision-making in women with suspected preeclampsia – the PreOS study protocol

References

• Hagmann H, Thadhani R, Benzing T, et al. The promise of angiogenic markers for the early diagnosis and prediction of preeclampsia. Clin Chem 2012;58:837–45
   PubMed Web of Science ®Google Scholar
• Steegers EA, von Dadelszen P, Duvekot JJ, Pijnenborg R. Pre-eclampsia. Lancet 2010;376:631–44
   PubMed Web of Science ®Google Scholar
• Lim K-H. Preeclampsia. Medscape Reference: Diseases & Conditions. Available from: http://emedicine.medscape.com/article/1476919-overview#aw2aab6b3 [last accessed 29 May 2014]
   Google Scholar
• Milne F, Redman C, Walker J, et al. The pre-eclampsia community guideline (PRECOG): how to screen for and detect onset of pre-eclampsia in the community. BMJ 2005;330:576–80
   PubMed Web of Science ®Google Scholar
• Duley L. Pre-eclampsia and the hypertensive disorders of pregnancy. Br Med Bull 2003;67:161–76
   PubMed Web of Science ®Google Scholar
• Duley L. Maternal mortality associated with hypertensive disorders of pregnancy in Africa, Asia, Latin America and the Caribbean. Br J Obstet Gynaecol 1992;99:547–53
   PubMedGoogle Scholar
• Hadker N, Garg S, Costanzo C, et al. Financial impact of a novel pre-eclampsia diagnostic test versus standard practice: a decision-analytic modeling analysis from a UK healthcare payer perspective. J Med Econ 2010;13:728–37
   PubMedGoogle Scholar
• Scazzocchio E, Figueras F. Contemporary prediction of preeclampsia. Curr Opin Obstet Gynecol 2011;23:65–71
   PubMed Web of Science ®Google Scholar
• Levine RJ, Maynard SE, Qian C, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004;350:672–83
   PubMed Web of Science ®Google Scholar
• Vatten LJ, Eskild A, Nilsen TI, et al. Changes in circulating level of angiogenic factors from the first to second trimester as predictors of preeclampsia. Am J Obstet Gynecol 2007;196:239.e1–6
   PubMed Web of Science ®Google Scholar
• Levine RJ, Lam C, Qian C, et al. (for the CPEP Study Group). Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med 2006;355:992–1005
   PubMed Web of Science ®Google Scholar
• Verlohren S, Galindo A, Schlembach D, et al. An automated method for the determination of the sFlt-1/PlGF ratio in the assessment of preeclampsia. Am J Obstet Gynecol 2010;202:e1–11
   PubMedGoogle Scholar
• Verlohren S, Herraiz I, Lapaire O, et al. New gestational phase-specific cutoff values for the use of the soluble fms-like tyrosine kinase-1/placental growth factor ratio as a diagnostic test for preeclampsia. Hypertension 2014;63:346–52
   PubMed Web of Science ®Google Scholar
• Villa PM, Hämäläinen E, Mäki A, et al. Vasoactive agents for the prediction of early- and late-onset preeclampsia in a high-risk cohort. BMC Pregnancy Childbirth 2013;13:110
   PubMed Web of Science ®Google Scholar
• Rana S, Powe CE, Salahuddin S, et al. Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia. Circulation 2012;125:911–19
   PubMed Web of Science ®Google Scholar
• Schiettecatte J, Russcher H, Anckaert E, et al. Multicenter evaluation of the first automated Elecsys sFlt-1 and PlGF assays in normal pregnancies and preeclampsia. Clin Biochem 2010;43:768–70
   PubMed Web of Science ®Google Scholar
• Schneider E, Gleixner A, Hänel R, et al. Technical performance of the first fully automated assays for human soluble fms-like tyrosine kinase 1 and human placental growth factor. Z Geburtshilfe Neonatol 2009;213:A8. Available from: https://www.thieme-connect.com/ejournals/abstract/10.1055/s-0029-1216308 [last accessed November 2014]
   Google Scholar
• Verlohren S, Herraiz I, Lapaire O, et al. The sFlt-1/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patients. Am J Obstet Gynecol 2012;206:e1–8
   Google Scholar
• Hund M, Verhagen-Kamerbeek WDJ, Reim M. PreOS (Preeclampsia Open Study) – prospective, open, non-interventional study evaluating the influence of the angiogenic biomarkers sFlt-1 and PlGF on decision-making of physicians in pregnant women with suspicion of preeclampsia. Presented at the 18th World Congress on Controversies in Obstetrics, Gynecology and Infertility (COGI); 2013 Oct 24–27; Vienna, Austria
   Google Scholar
• ACOG Committee on Practice Bulletins – Obstetrics. ACOG Practice Bulletin: diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. Obstet Gynecol 2002;99:159–67
   Google Scholar
• Brown MA, Lindheimer MD, de Swiet M, et al. The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy 2001;20:IX–XIV
   PubMed Web of Science ®Google Scholar
• Magann EF, Martin NJ. Twelve steps to optimal management of HELLP syndrome. Clin Obstet Gynecol 1999;42:532–50
   PubMed Web of Science ®Google Scholar
• Simhan HN, Caritis SN. Prevention of preterm delivery. N Engl J Med 2007;357:477–87
   PubMed Web of Science ®Google Scholar
• Stepan H. Intrauterine Wachstumsretardierung. In: Wacker J, Bastert G, Sillem M, Beckmann MW, eds. Therapiehandbuch Gynäkologie und Geburtshilfe. Heidelberg: Springer Medizin; 2007:45–50
   Google Scholar
• Von Dadelszen P, Magee LA, Roberts JM. Subclassification of preeclampsia. Hypertens Pregnancy 2003;22:143–8
   PubMed Web of Science ®Google Scholar
• Roche Diagnostics GmbH. Elecsys PlGF immunoassay. Package insert. 2013–08, V 5. Available from: http://www.rochecanada.com/fmfiles/re7234008/package_inserts/05144671190_PLGF_EN_PI_V5.pdf [last accessed October 2014]
   Google Scholar
• Roche Diagnostics GmbH. Elecsys sFlt-1 immunoassay. Package insert. 2013–08, V 5. Available from: http://www.rochecanada.com/fmfiles/re7234008/package_inserts/sFlt-1-05109523190-English-CAN-V5.pdf [last accessed October 2014]
   Google Scholar
• European Commission DG Enterprise and Industry Guidelines on a Medical Devices Vigilance System. MEDDEV 2.12.–1 rev. 6. 2009. Available from: http://ec.europa.eu/health/medical-devices/files/meddev/2_12_1-rev_6-12-2009_en.pdf [last accessed October 2014]
   Google Scholar